HIGHLIGHTS
- who: ufeffAuraufeff ufeffTemereancaufeff from the University of Bucharest have published the research: Strategies to overcome HIV drug resistance-current and future perspectives, in the Journal: (JOURNAL) of March/31,/2022
- what: Life-long HIV treatment and drug resistance are still a challenge that requires constant efforts to identify new generations of antiretroviral agents.
- how: The results showed that ibalizumab significantly decreased the viral load 7 days after being added to the failing antiretroviral regimen.
SUMMARY
The prevalence of three and fourclass drug-resistant viruses is estimated to be 5 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.